Endocyte Reports Fourth Quarter and Year End 2015 Financial Results and Provides Clinical and Pipeline Update
- EC1456 and EC1169 Advance in Phase 1 Dose Escalation Studies - - Expansion Phase of Trials in Targeted Patients Expected to Yield Efficacy Data in 2016 - - Two New Clinical Development Candidates to be Announced in 2016 - - Conference Call Today at 4:30 …